Perspective Therapeutics (CATX) Assets (2016 - 2026)
Perspective Therapeutics' Assets history spans 16 years, with the latest figure at $410.8 million for Q1 2026.
- On a quarterly basis, Assets rose 24.72% to $410.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $410.8 million, a 24.72% increase, with the full-year FY2025 number at $267.0 million, down 21.73% from a year prior.
- Assets hit $410.8 million in Q1 2026 for Perspective Therapeutics, up from $267.0 million in the prior quarter.
- Over the last five years, Assets for CATX hit a ceiling of $410.8 million in Q1 2026 and a floor of $58.1 million in Q4 2022.
- Historically, Assets has averaged $218.6 million across 5 years, with a median of $267.0 million in 2025.
- Biggest five-year swings in Assets: surged 253.93% in 2024 and later dropped 24.63% in 2025.
- Tracing CATX's Assets over 5 years: stood at $58.1 million in 2022, then skyrocketed by 68.51% to $97.9 million in 2023, then soared by 248.45% to $341.1 million in 2024, then dropped by 21.73% to $267.0 million in 2025, then soared by 53.86% to $410.8 million in 2026.
- Business Quant data shows Assets for CATX at $410.8 million in Q1 2026, $267.0 million in Q4 2025, and $294.8 million in Q3 2025.